Amedisys, Inc. (AMED) Financials
Stock symbol AMED is outdated, potentially delisted? Maybe it is available on other exchange?
AMED Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 2.2 billion | 940.5 million |
| March 31, 2025 | 2.2 billion | 939.5 million |
| Dec. 31, 2024 | 2.1 billion | 958.7 million |
| Sept. 30, 2024 | 2.1 billion | 938.7 million |
AMED Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | 66.5 million | 7.9 million |
| March 31, 2025 | -4.9 million | 6.8 million |
| Dec. 31, 2024 | 69.2 million | 8.2 million |
| Sept. 30, 2024 | 104.2 million | 6.2 million |
AMED Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2025 | 29.1 million |
| March 31, 2025 | 61.8 million |
| Dec. 31, 2024 | -25.1 million |
| Sept. 30, 2024 | 16.5 million |
AMED Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | 337.3 million | 387.7 million | 87.3 million |
| March 31, 2025 | 284.9 million | 388.6 million | 81.5 million |
| Dec. 31, 2024 | 303.2 million | 396.3 million | 82.0 million |
| Sept. 30, 2024 | 245.5 million | 403.8 million | 85.8 million |
AMED Shares Outstanding
AMED Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | 700000 | - | 196.3 million | - |
| March 31, 2025 | 1.2 million | - | 196.2 million | - |
| Dec. 31, 2024 | 1.1 million | - | 202.7 million | - |
| Sept. 30, 2024 | 1.4 million | - | 198.3 million | - |
AMED Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | 621.9 million | 130.3 million |
| March 31, 2025 | 594.8 million | 334.1 million |
| Dec. 31, 2024 | 598.1 million | 344.6 million |
| Sept. 30, 2024 | 587.7 million | 337.6 million |
AMED Revenue by Segment
Graph available only for paid members. Upgrade to see it.
AMED
Price: $100.99
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.57 USD
P/E Ratio: 38.33
Exchange: NMS
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 187889
Ebitda: 29.5 millionMarket Capitalization: 3.2 billion